Scientists dive deep into skin cells to unlock scleroderma secrets
NCT ID NCT05273138
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at skin and blood samples from 40 people with systemic sclerosis (scleroderma) to understand why the disease causes scarring. Researchers will analyze individual cells to see how different types of fibroblasts and immune cells behave. The goal is to find new clues that could lead to better treatments in the future.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could reveal new targets for treating systemic sclerosis by showing how skin and immune cells interact.
- What could go wrong
- This is an observational study with only 40 participants, so findings may not apply to all patients. It does not test any treatment directly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLEROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hop Claude Huriez Chu Lille
RECRUITINGLille, 59037, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Immune clues in the blood may foretell heart trouble
- Blood particles may reveal hidden clues to scleroderma complications
- Could a simple injection dissolve painful calcium lumps in rare diseases?
- Finger injections aim to loosen stiff hands in scleroderma
- Continued anifrolumab treatment studied for lupus and related diseases
- Blood thinner may stop autoimmune disease before it starts